Scott M Whitcup's Net Worth
$26.6 Million
Who is Scott M Whitcup?
Scott M Whitcup has an estimated net worth of $26.6 Million. This is based on reported shares across multiple companies, which include Nightstar Therapeutics plc, Menlo Therapeutics Inc., Adverum Biotechnologies, Inc., ALLERGAN INC, QUESTCOR PHARMACEUTICALS INC, and AVANIR PHARMACEUTICALS.
SEC CIK
Scott M Whitcup's CIK is 0001298941
Past Insider Trading and Trends
2013 was Scott M Whitcup's most active year for acquiring shares with 15 total transactions. Scott M Whitcup's most active month to acquire stocks was the month of January. 2013 was Scott M Whitcup's most active year for disposing of shares, totalling 24 transactions. Scott M Whitcup's most active month to dispose stocks was the month of February. 2014 saw Scott M Whitcup paying a total of $12,932,722.05 for 167,015 shares, this is the most they've acquired in one year. In 2014 Scott M Whitcup cashed out on 247,403 shares for a total of $12,468,137.88, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nightstar Therapeutics plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -74.57K |
$25.50 | -$1,901,484.00 |
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Menlo Therapeutics Inc. (VYNE) Snapshot price: $1.87
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Adverum Biotechnologies, Inc. (ADVM) Snapshot price: $6.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ALLERGAN INC No price found
Executive VP, R&D, CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -20.62K |
—
|
—
|
0
|
Feb 20 - Mar 17
| |||
Form 4
| +0.77% | 132 |
$234.00 | -$18,720.00 | 17.18K |
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
| -1.64% | -284.00 |
$124.57 | -$35,377.88 | 17.04K |
Feb 14
| |||
Form 4
|
—
|
0
|
$86.89 | -$2,596,650.00 | 17.33K |
Scheduled
|
Jan 14
| ||
Form 4
|
—
|
0
|
$84.89 | -$2,428,650.00 | 17.33K |
Scheduled
|
Jan 8
| ||
Form 4/A
|
—
|
0
|
$73.97 | -$1,830,730.00 | 17.33K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$108.80 | -$3,590,400.00 | 17.33K |
Scheduled
|
Dec 20
| ||
Form 4
|
—
|
0
|
$72.47 | -$2,397,450.00 | 17.33K |
Scheduled
|
Dec 20
| ||
Form 4
|
—
|
0
|
$75.58 | -$946,594.25 | 17.33K |
Scheduled
|
Apr 11
| ||
Form 4
|
—
|
0
|
$75.58 | -$1,040,425.75 | 17.33K |
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
$76.47 | -$563,702.40 | 17.33K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$74.08 | -$871,061.40 | 17.33K |
Scheduled
|
Mar 26
| ||
Form 4
|
—
|
0
|
$74.08 | -$463,898.60 | 17.33K |
Scheduled
|
Mar 21 - Mar 25
| ||
Form 4
| -23.14% | -5.22K |
$108.08 | -$563,961.44 | 17.33K |
Feb 20 - Feb 21
| |||
Form 4
| -1.89% | -434.00 |
$108.02 | -$46,880.68 | 22.55K |
Feb 15
| |||
Form 4
|
—
|
0
|
$69.02 | -$1,333,440.00 | 22.98K |
Scheduled
|
Jan 4
| ||
Form 4
|
—
|
0
|
$60.68 | -$415,541.20 | 22.98K |
Scheduled
|
Dec 7
| ||
Form 4
|
—
|
0
|
$62.42 | -$322,875.00 | 22.98K |
Scheduled
|
Oct 17
| ||
Form 4
|
—
|
0
|
$61.42 | -$375,450.00 | 22.98K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$60.42 | -$90,874.35 | 22.98K |
May 30
| |||
Form 4
|
—
|
0
|
$61.07 | -$92,812.50 | 22.98K |
May 16
| |||
Form 4
| -0.20% | -45.00 |
$87.27 | -$3,927.15 | 22.98K |
Feb 22
| |||
Form 4
| +2.42% | 544 |
—
|
—
| 23.02K |
Feb 17
| |||
Form 4
| -6.14% | -1.47K |
$88.11 | -$129,514.35 | 22.48K |
Feb 14
| |||
Form 4
|
—
|
0
|
$56.41 | -$302,339.95 | 23.95K |
Scheduled
|
May 18
| ||
Form 4
| -2.48% | -607.95 |
$80.85 | -$49,151.93 | 23.95K |
May 11
| |||
Form 4
|
—
|
0
|
$54.86 | -$103,760.00 | 24.56K |
Scheduled
|
May 4
| ||
Form 4
| +3.50% | 830 |
—
|
—
| 24.56K |
Feb 17
| |||
Form 4
| -14.43% | -4.00K |
$75.72 | -$302,891.20 | 23.73K |
Feb 17
| |||
Form 4
|
—
|
0
|
$54.79 | -$441,475.35 | 27.73K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$53.62 | -$200,190.72 | 27.73K |
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$48.80 | -$236,624.28 | 27.73K |
Scheduled
|
Mar 31
| ||
Form 4
| +0.43% | 120 |
—
|
—
| 27.73K |
Feb 22
| |||
Form 4
| -2.67% | -756.00 |
$58.97 | -$44,577.54 | 27.61K |
Feb 12
| |||
Form 4
|
—
|
0
|
$47.30 | -$238,450.40 | 28.36K |
Scheduled
|
Dec 22
| ||
Form 4
|
—
|
0
|
$45.30 | -$129,031.50 | 28.36K |
Scheduled
|
Sep 16
| ||
Form 4
|
—
|
0
|
$42.87 | -$41,912.60 | 28.36K |
Scheduled
|
Jul 30
| ||
Form 4
| +54.46% | 10K |
—
|
—
| 28.36K |
Feb 20
| |||
Form 4
| -3.08% | -584.00 |
$38.37 | -$22,405.16 | 18.36K |
Feb 2
| |||
Form 4
| +46.31% | 6K |
—
|
—
| 18.95K |
Feb 14
| |||
Form 4
| -5.32% | -728.00 |
$66.66 | -$48,524.84 | 12.95K |
Feb 6
| |||
Form 4
| -13.68% | -2.17K |
$64.00 | -$138,752.00 | 13.68K |
Jan 30
| |||
Form 4
|
—
|
0
|
$114.94 | -$124,399.12 | 7.92K |
Scheduled
|
May 31 - Jun 1
| ||
Form 4
|
—
|
0
|
$115.63 | -$1,874.00 | 7.92K |
Scheduled
|
May 24
| ||
Form 4
| +9.42% | 682 |
—
|
—
| 7.92K |
Feb 2
| |||
Form 4
| -19.90% | -1.80K |
$115.80 | -$208,324.20 | 7.24K |
Jan 31
| |||
Form 4
|
—
|
0
|
$104.28 | -$228,515.70 | 9.04K |
Scheduled
|
Nov 20
| ||
Form 4
|
—
|
0
|
$82.92 | -$564,300.00 | 9.04K |
Jul 11
| |||
Form 4
|
—
|
0
|
$78.63 | -$580,983.84 | 9.04K |
Jun 16
| |||
Form 4
|
—
|
0
|
$78.63 | -$263,700.00 | 9.04K |
Jun 12
| |||
Form 4
|
—
|
0
|
$80.56 | -$311,300.00 | 9.04K |
Apr 3
| |||
Form 4
| +12.69% | 1.02K |
—
|
—
| 9.04K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
QUESTCOR PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.18K |
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
∞
| 4.18K |
—
|
—
| 4.18K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |